1. Xia, Pu, Liu, Da-Hua, Wang, Dan, Wen, Gui-Min, Zhao, Zhen-Ying. 2023. SLC3A2, as an indirect target gene of ALDH2, exacerbates alcohol-associated liver cancer via the sphingolipid biosynthesis pathway. In Free radical biology & medicine, 206, 125-133. doi:10.1016/j.freeradbiomed.2023.07.002. https://pubmed.ncbi.nlm.nih.gov/37406742/
2. Liu, Hailong, Deng, Zengfa, Yu, Baoxi, Zeng, Anyu, Fu, Ming. 2022. Identification of SLC3A2 as a Potential Therapeutic Target of Osteoarthritis Involved in Ferroptosis by Integrating Bioinformatics, Clinical Factors and Experiments. In Cells, 11, . doi:10.3390/cells11213430. https://pubmed.ncbi.nlm.nih.gov/36359826/
3. Ma, Heng, Chen, Xianlong, Mo, Shengwei, Yu, Shuangni, Chen, Jie. 2023. Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma. In Cell death and differentiation, 30, 1988-2004. doi:10.1038/s41418-023-01188-z. https://pubmed.ncbi.nlm.nih.gov/37479744/
4. Liu, Jinyun, Xia, Xiaojun, Huang, Peng. 2020. xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling. In Molecular therapy : the journal of the American Society of Gene Therapy, 28, 2358-2366. doi:10.1016/j.ymthe.2020.08.021. https://pubmed.ncbi.nlm.nih.gov/32931751/
5. Xu, Yuheng, Weng, Wanqi, Weng, Yuhao, Wang, Zhaotao, Zhang, Shizhen. 2024. Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas. In Scientific reports, 14, 15758. doi:10.1038/s41598-024-66484-1. https://pubmed.ncbi.nlm.nih.gov/38977800/